Elo Mutual Pension Insurance Co Purchases 851 Shares of Agilent Technologies, Inc. (NYSE:A)

Elo Mutual Pension Insurance Co lifted its position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 3.4% during the fourth quarter, HoldingsChannel reports. The firm owned 25,544 shares of the medical research company’s stock after buying an additional 851 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Agilent Technologies were worth $3,551,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Gotham Asset Management LLC boosted its position in shares of Agilent Technologies by 246.7% during the third quarter. Gotham Asset Management LLC now owns 54,437 shares of the medical research company’s stock worth $6,087,000 after purchasing an additional 38,737 shares in the last quarter. UBS Group AG lifted its position in Agilent Technologies by 84.5% in the 4th quarter. UBS Group AG now owns 325,695 shares of the medical research company’s stock valued at $45,281,000 after acquiring an additional 149,159 shares in the last quarter. TD Asset Management Inc lifted its position in Agilent Technologies by 27.1% in the 4th quarter. TD Asset Management Inc now owns 1,609,420 shares of the medical research company’s stock valued at $223,758,000 after acquiring an additional 343,175 shares in the last quarter. DAVENPORT & Co LLC lifted its position in Agilent Technologies by 77.7% in the 4th quarter. DAVENPORT & Co LLC now owns 4,882 shares of the medical research company’s stock valued at $679,000 after acquiring an additional 2,135 shares in the last quarter. Finally, Wells Fargo & Company MN lifted its position in Agilent Technologies by 18.2% in the 4th quarter. Wells Fargo & Company MN now owns 508,184 shares of the medical research company’s stock valued at $70,653,000 after acquiring an additional 78,225 shares in the last quarter.

Analyst Ratings Changes

Several equities research analysts have issued reports on A shares. Citigroup lowered their price target on shares of Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. Oppenheimer lifted their price target on shares of Agilent Technologies from $67.00 to $90.00 and gave the company an “outperform” rating in a research note on Tuesday, March 26th. Barclays lowered their price target on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating on the stock in a research note on Friday, May 31st. Stifel Nicolaus lowered their price target on shares of Agilent Technologies from $163.00 to $151.00 and set a “buy” rating on the stock in a research note on Thursday, May 30th. Finally, UBS Group lowered their price objective on shares of Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $136.50.

Read Our Latest Stock Report on Agilent Technologies

Insider Transactions at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at $3,274,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at $3,274,050. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Philip Binns sold 2,827 shares of Agilent Technologies stock in a transaction that occurred on Monday, March 25th. The shares were sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the transaction, the senior vice president now directly owns 9,997 shares in the company, valued at $1,474,957.38. The disclosure for this sale can be found here.

Agilent Technologies Stock Performance

NYSE A opened at $133.07 on Tuesday. The company has a quick ratio of 1.64, a current ratio of 2.15 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $38.82 billion, a P/E ratio of 31.46, a P/E/G ratio of 4.51 and a beta of 1.07. Agilent Technologies, Inc. has a 12-month low of $96.80 and a 12-month high of $155.35. The firm has a 50-day moving average price of $141.86 and a two-hundred day moving average price of $138.06.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings data on Wednesday, May 29th. The medical research company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business’s revenue for the quarter was down 8.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.27 EPS. Analysts anticipate that Agilent Technologies, Inc. will post 5.25 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be issued a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio is currently 22.22%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Further Reading

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.